When was Bayer founded?

Bayer was founded in 1863 and raised its 1st funding round 147 years after it was founded.

Where is Bayer located?

Bayer is headquartered in Leverkusen, Germany. It is registered at St Louis, Missouri.

How many employees does Bayer have?

As of Sep 30, 2026, the latest employee count at Bayer is 95959.

Is Bayer a funded company?

Bayer is a funded company, having raised an undisclosed amount across 26 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 15, 2010.

When was the latest funding round of Bayer?

Bayer's latest funding was a $***** Grant (prize money) round on Oct 21, 2022, with participation from 1 investor.

Where does Bayer rank among its competitors?

Bayer ranks 1st amongst 208 active competitors, of which 13 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Wockhardt, which secured $118M in Nov, 2024.

Who are the top competitors of Bayer?

Bayer's top competitors include Biological E, Wockhardt and Lupin. Among them, Wockhardt secured the most recent funding round in November, 2024.

Bayer - 2026 Company Profile, Team, Funding & Competitors

Bayer is a public company based in Leverkusen (Germany), founded in 1863. It operates as a Manufacturer of drugs. Bayer has raised an undisclosed amount in funding. The company has 208 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Biological E, Wockhardt and Lupin.

Company Details

Manufacturer of drugs. It targets women's health, cardiology, oncology, hematology, ophthalmology, and radiology.

Website: www.bayer.com/
Social
Email ID: *****@bayer.com
Phone Number: +49 **********
Registered Address: St Louis, Missouri

Key Metrics

Founded Year

1863

Location

Leverkusen, Germany

Stage

Public

Latest Funding Round

Grant (prize money), Oct 21, 2022, $*****

Investors

Digital Pharma Lab & 10 more

Ranked

1^st among 208 active competitors

Employee Count

95,959 as on Sep 30, 2026

Investment & Acquisitions

Leaf & 94 more

Similar Companies

Biological E & 221 more

Exit Details

Public

View Bayer's full profile

Bayer is associated with 22 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
BAYER a BAYER s.r.o. CIN: 63217406 , Czech Republic, Active	Mar 09, 1995	-	-
HELF, spol. s r.o. CIN: 62363417 , Czech Republic, Active	Mar 09, 1995	-	-
BLOK, spol. s r.o. CIN: 46995722 , Czech Republic, Active	Dec 18, 1992	-	-
SKSK s.r.o. CIN: 28846770 , Czech Republic, Active	Apr 05, 2012	-	-
Baier 2 spol. s r.o. CIN: 21384789 , Czech Republic, Active	Apr 01, 2024	-	-
Czech Pills Group s.r.o. CIN: 19664061 , Czech Republic, Active	Aug 30, 2023	-	-
BAYER CZ s.r.o. CIN: 09916008 , Czech Republic, Active	Feb 12, 2021	-	-
commerz-data.eu, spol. s r.o. CIN: 06487882 , Czech Republic, Active	Oct 03, 2017	-	-
Bayer CIN: 40103182449 , Latvia, Active	Jul 24, 2008	€1M - €10M (As on Dec 31, 2024)	44 (As on Dec 31, 2022)	-
BAYER AEH LIMITED CIN: 863087 , United Kingdom, Active	Nov 01, 1965	-	-
BAYER FULL TRANSPORT LTD CIN: 12657085 , United Kingdom, Active	Jun 08, 2020	-	1 (As on Jun 30, 2021)
BAYER BIOSCIENCE PRIVATE LIMITED CIN: U74899MH1977PTC179722 , India, Active	Feb 28, 1977	₹100 - ₹500 Cr (As on Mar 31, 2025)	-
MAHYCO MONSANTO BIOTECH (INDIA) PRIVATE LIMITED CIN: U73100MH1997PTC111505 , India, Active	Oct 23, 1997	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
BAYER INVESTMENTS INDIA PRIVATE LIMITED CIN: U65191MH2014PTC254886 , India, Active	Mar 24, 2014	₹50 - ₹100 Cr (As on Mar 31, 2025)	-
BAYER ZYDUS PHARMA PRIVATE LIMITED CIN: U24233MH2011PTC213118 , India, Amalgamated	Feb 07, 2011	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	688 (As on Oct 31, 2024)
BAYER SCIENCE AND INNOVATION PRIVATE LIMITED CIN: U24110MH1996PTC096340 , India, Active	Jan 16, 1996	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	1160 (As on Mar 31, 2024)
BAYER FOUNDATION INDIA CIN: U85191MH2011NPL220674 , India, Active	Aug 08, 2011	0 - ₹10 Cr (As on Mar 31, 2025)	-
BAYER PHARMACEUTICALS PRIVATE LIMITED CIN: U05195MH1998PTC116021 , India, Active	Jul 29, 1998	₹1,000+ Cr (As on Mar 31, 2026)	1333 (As on Feb 01, 2026)
BAYER CROPSCIENCE LIMITED CIN: L24210MH1958PLC011173 , India, Active	Sep 09, 1958	₹1,000+ Cr (As on Mar 31, 2025)	1083 (As on Feb 29, 2024)
BAYER VAPI PRIVATE LIMITED CIN: U99999GJ1990PTC049322 , India, Active	Aug 08, 1990	₹1,000+ Cr (As on Mar 31, 2025)	1166 (As on Feb 01, 2026)
Bayer Aktiengesellschaft CIN: HRB48248 , Germany, Active	Jan 14, 1952	€1B+ (As on Dec 31, 2023)	99538 (As on Dec 31, 2020)
BAYER CORPORATION CIN: 251339219 , United States, Active	Dec 26, 999	-	313 (As on Dec 31, 2024)	-

Bayer got listed on Jan 10, 1953.

Click here to take a look at Bayer's IPO in detail

Bayer has raised funding over 26 rounds. Its first funding round was on Jul 15, 2010. Its latest funding round was a Grant (prize money) round on Oct 21, 2022 for $*****. 1 investor participated in its latest round. Bayer has 11 institutional investors.

Here is the list of recent funding rounds of Bayer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 21, 2022	8519995	Grant (prize money)	8299123	8674245	6726414	2252170
Jun 01, 2021	6495023	Grant (prize money)	3108329	6964930	8533296	Europa
May 31, 2021	8493642	Grant (prize money)	7961271	2730192	7211477	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Bayer's funding rounds and investors

Bayer's Board of Directors

Bayer's board has 7 active members. Sanjiv Rangrass, Radhika Govind Rajan, Ravi Moti Kirpalani, Thomas Hoffmann, Simon Thorsten Wiebusch, Jana Marlen Ackermann and Vinit Rajesh Jindal are independent board members.

Here is the list of Bayer's board of directors:

Name	Type	Representing	Status	Duration
Sanjiv Rangrass	Independent board member	-	Current	1y 3m
slqquam	Independent board member	-	Current	5y 2m
wqbvvkv	Independent board member	-	Current	6y 7m
hausegi	Independent board member	-	Current	7y 2m
pnnfyns	Independent board member	-	Current	9y 2m
mcbnib{	Independent board member	-	Current	4y 8m
fhlccvt	Independent board member	-	Current	2y 7m

Bayer's employee count trend

Bayer has 95,959 employees as of Sep 26. Here is Bayer's employee count trend over the years:

Uncover Bayer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bayer include Biological E, Wockhardt and Lupin. Here is the list of Top 10 competitors of Bayer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Biological E 1953, Hyderabad (India), Late Stage	Developer of vaccines for treating multiple diseases	$60M	Gates, IFC & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	72/100
4th	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	$6.64M	Cipher International, AbbVie & 5 others	71/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
7th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
8th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 3 others	68/100
9th	Aurobindo Pharma 1986, Hyderabad (India), Public	Provider of generic biocatalytic products	-	Affirma Capital, India Capital Growth & 4 others	66/100
10th	Orchid Pharma 1992, Chennai (India), Public	Company offering a suite of pharmaceutical solutions	-	Societe Generale, MIT & 6 others	66/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Bayer's competitors? Click here to see the top ones

Bayer has made 56 investments in companies including Leaf and Ukko. Bayer has also acquired 39 companies including Perfuse Therapeutics and Cara Care.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 11, 2026	Investments	Leaf	2018	Los Angeles (United States)
May 06, 2026	Acquisition	Perfuse Therapeutics	2018	San Francisco (United States)
Jan 08, 2026	Investments	Ukko	2017	Palo Alto (United States)